Obesity Medicine

Latest News

A Half Dose of Semaglutide Yields Weight Loss Equivalent to a Whole Dose in Combination with Online Clinic Program  / image credit University of Cophenhagen
A Half Dose of Semaglutide Yields Weight Loss Equivalent to Clinical Trial Doses in Combination with Online Support Program

May 13th 2025

Semaglutide dosing was individually tailored for adults with obesity and supported with app-based coaching on diet, physical activity, and other lifestyle factors.

Tirzepatide Demonstrates Greater Weight Loss Than Semaglutide in Head-to-Head Study
Tirzepatide Demonstrates Greater Weight Loss Than Semaglutide in Head-to-Head Study

May 12th 2025

Genetic Risk Score Identifies Individuals Likely to Report Adverse Events from GLP-1 Mimetic Therapy / image credit Andres Acosta Phenomix Sciences
Genetic Risk Score Identifies Individuals Likely to Report Adverse Events from GLP-1 Mimetic Therapy

May 12th 2025

Tirzepatide Switch Outperforms Dulaglutide Dose Escalation in T2D: Daily Dose / image credit: ©New Africa/AdobeStock
Tirzepatide Switch Outperforms Dulaglutide Dose Escalation in T2D: Daily Dose

May 5th 2025

Precision Obesity Medicine Breakthroughs To Lead DDW 2025 Presentations from Phenomix Sciences  / image courtesy of Digestive Disease Week
Precision Obesity Medicine Breakthroughs To Lead DDW 2025 Presentations from Phenomix Sciences

April 25th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.